RP | IMRT | p | |
---|---|---|---|
No. of patients | 993 | 207 | |
Mean age (95% CI) | 63 (62.6–63.5) | 70 (69–71) | p < 0.001* |
Mean PSA (95% CI) | 9.8 (9.1–10.5) | 13.6 (11.8–16.6) | p < 0.001* |
Mean % PCa biopsy (95% CI) | 17.6 (16.1–18.9) | 25.7 (22–29.6) | p < 0.001* |
DRE | p < 0.001† | ||
T1 (n/%) | 537/ 53.7% | 84/ 40.6% | |
T2 (n/%) | 175/ 18% | 70/ 34% | |
T3 (n/%) | 29/ 4% | 53/ 26% | |
T4 (n/%) | 0 | 0 | |
Unknown (n/%) | 266/26.7% | 0 | |
D’Amico classification | p < 0.001† | ||
Low risk (n/%) | 194/19.5% | 40/19.3% | |
Intermediate risk (n/%) | 525/52.9% | 79/37.7 | |
High risk (n/%) | 216/21.7% | 78/38% | |
Unknown (n/%) | 56/5.6% | 10/4.89 |